News
Can Rite Aid’s C-Suite Shake-Up Be Good News?
Only months after Rite Aid's (NYSE: RAD) planned merger with Walgreens Boots Alliance (NASDAQ: WBA) disintegrated, Rite Aid's CEO Ken Martindale left the company to become the CEO of GNC Holdings,....
Is Boston Beer About to Be Acquired?
When Boston Beer Company (NYSE: SAM) announced better-than-expected second-quarter results in late July, shares surged as much as 22% the following day -- and with good reason. Boston Beer's....
Better Buy: Wal-Mart Stores Inc. vs. Target
In one corner stands Wal-Mart Stores (NYSE: WMT), heavyweight champ of the U.S. retail industry with nearly $500 billion in annual sales. In the other corner is Target (NYSE: TGT) -- an underdog....
Kroger Unveils Kitchen 1883 -- Should Investors Cheer or Jeer?
If you were a shareholder of Kroger (NYSE: KR) over the past year, you know it has not been a pleasant ride. The stock is down mightily as a result of a) food deflation and the accompanying....
McCormick Boosts Guidance Following RB Foods Acquisition
McCormick (NYSE: MKC) has cashed in on rising demand for spices and flavorings for foods, and a successful corporate strategy has made the company a leader in its niche. Consumers buy McCormick's....
Philip Morris International Makes $1 Billion Investment in Smoking Alternatives
Twenty years ago, cigarette maker Liggett Group upended the tobacco world when it broke ranks with the rest of the industry and agreed to settle a lawsuit with 22 states, becoming the first....
Artisans, Hipsters, and Suits
Earlier this month, consumer packaged-goods giant Nestle SA (NASDAQOTH: NSRGY) announced a deal to snap up a controlling stake in upscale coffee-purveyor Blue Bottle Coffee Company for a sum....
5 Essential Themes in PepsiCo's Upcoming Earnings
Through the first nine months of this year, PepsiCo Inc. (NYSE: PEP) stock has turned in a credible performance, generating a total return of nearly 10%, which is just a few percentage points shy....
Anemic Earnings Sent Rite Aid's Shares Down Today
After Rite Aid (NYSE: RAD) released a fiscal second-quarter report Thursday morning showing sales and adjusted net income that were lower year over year, shares of the drugstore chain tumbled, and....
5 Key Things You Need to Know From Rite Aid's Q2 Results
Just when you thought things couldn't get any worse for Rite Aid (NYSE: RAD), they did.The pharmacy chain's stock has taken a beating throughout 2017 with increasing uncertainty over a....
3 High-Yield Stocks With Virtual Monopolies
In the United States, monopolies technically aren't supposed to exist, thanks to the Sherman Antitrust Act of 1890. However, there are a handful of U.S.-based companies that do, in fact, own a....
Why I Love Kimberly-Clark Corporation
Investors are a bit down on Kimberly-Clark (NYSE: KMB) these days. Shares are trailing the market as the consumer goods giant struggles through a period of slowing growth. Step back and take a....
5 Key Highlights From FedEx Corporation's Q1 Earnings Call
FedEx (NYSE: FDX) exited its 2017 fiscal year with strong earnings momentum, posting 14% growth in adjusted earnings per share for the full year. However, the package delivery giant stumbled out....
3 Stocks Every Retiree Should Consider Buying
Don't look now, but Americans are living an average of nine years longer now than they were in 1960. This means sitting on your money during retirement may not work. Instead, you'll need to remain....
3 Dividend Stocks That Thrive in Both Bull and Bear Markets
The stock market has been in a bull market for over eight years now, and it's only a matter of time before we see a bear market again. The problem is, no one knows when the bear market will come.....
How Much Do Retailers Actually Pay Hourly Workers?
Target (NYSE: TGT) made news earlier this week by making public plans to increase its minimum hourly wage for all employees to $11 in October. The chain also pledged to increase wages to a....
Payer Pushback Is Weighing Down Retail Pharmacy Stocks
Prescription volume is climbing at Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS), yet growth rates at these pharmacy retailers are slowing. Why aren't retail pharmacies....
Has Anheuser-Busch Finally Had Its Fill of Craft Beer?
Too much of a good thing can be, well, too much. Anheuser-Busch InBev (NYSE: BUD) has been chugging down so many pint-sized craft breweries that it is giving itself a bad hangover from the binge,....
McCormick & Company Earnings: 3 Things to Watch This Week
McCormick & Company (NYSE: MKC) is due to announce its fiscal third-quarter results before the market opens on Thursday, Sept. 28. Here are a few key trends investors should be watching in the....
Rite Aid Stock Has a Lot to Prove on Thursday
Regulators finally gave Rite Aid (NYSE: RAD) clearance for an asset sale last week, but it's apparently a case of "too little, too late" for investors who have seen the drugstore operator get....
Best Buy: The Coca-Cola Co vs. PepsiCo, Inc. vs. Procter & Gamble Co
They are three of the biggest names among dividend investors. Coca-Cola (NYSE: KO), Procter & Gamble (NYSE: PG) , and PepsiCo (NYSE: PEP) have been offering investors dividend increases for a....
3 Soda Stocks You May Be Overlooking
Soda giants Coca-Cola (NYSE: KO) and PepsiCo (NYSE: PEP) have produced solid returns for investors this year that roughly track those of the broader market. But thanks in part to their massive....
Why GMO Crops (Probably) Can't Compete for This $22 Billion Ingredient Opportunity
You may not realize it yet, but the bioeconomy is at a historic crossroads. The world's largest agricultural companies are on the cusp of developing genetically engineered crops capable of....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Should Craft Brewers Be Frightened of What This New Survey Says?
Who cares who makes your beer? So long as it tastes good, that's what's important. That's pretty much the argument Anheuser-Busch InBev (NYSE: BUD) makes when scooping up a craft brewery, and it's....